Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

por Minting Chen, Keying Zhong, Jincheng Tan, Mingjing Meng, Chok Mei Liu, Baisen Chen, Chunhua Huang, Hoi Leong Xavier Wong, Zhaoxiang Bian, Tao Su, Hiu Yee Kwan
Publicado 2021

Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level

por Xianjing Hu, Sarwat Fatima, Minting Chen, Tao Huang, Yuen Wa Chen, Ruihong Gong, Hoi Leong Xavier Wong, Rongmin Yu, Liyan Song, Hiu Yee Kwan, Zhaoxiang Bian
Publicado 2021